[Are we monitoring, in primary care, dyslipaemia in patients with ischaemic cardiopathy?].
作者信息
Rodríguez Monje M Teresa, Sanz Cuesta Teresa, Fernández Martín Cristina, Rodríguez Barniol Mónica
出版信息
Aten Primaria. 2007 Dec;39(12):675-6. doi: 10.1157/13113964.
Abstract
摘要
相似文献
1
[Are we monitoring, in primary care, dyslipaemia in patients with ischaemic cardiopathy?].
Aten Primaria. 2007 Dec;39(12):675-6. doi: 10.1157/13113964.
2
Therapeutic inertia in the outpatient management of dyslipidemia in patients with ischemic heart disease. The inertia study.
Rev Esp Cardiol. 2010 Dec;63(12):1428-37. doi: 10.1016/s1885-5857(10)70277-2.
3
[Magneto-peloidotherapy and hydrogen sulfide baths for the correction of dyslipidemia and immune inflammation in patients with ischemic heart disease during resort treatment].
Vopr Kurortol Fizioter Lech Fiz Kult. 2009 Jul-Aug(4):17-9.
4
[Resources for the diagnosis of hypertensive cardiopathy at the primary care level].
Rev Esp Cardiol. 1997;50 Suppl 4:3-9.
5
[Dyslipidemia management in patients with high cardiovascular risk in Spain. ALMA study].
Aten Primaria. 2018 Jan;50(1):35-43. doi: 10.1016/j.aprim.2017.02.004. Epub 2017 Jun 12.
6
Management of ischaemic heart disease in primary care: towards better practice. STaRNet. South Thames Region Network.
J Public Health Med. 1999 Jun;21(2):179-84. doi: 10.1093/pubmed/21.2.179.
7
[Secondary prevention of ischaemic cardiopathy in a primary care center].
Aten Primaria. 2003 May 31;31(9):614-5. doi: 10.1016/s0212-6567(03)79227-0.
8
Predictive factors of mental disorders in patients with suspected ischaemic cardiopathy.
Eur J Epidemiol. 2001;17(9):835-40. doi: 10.1023/a:1015614010877.
9
10
[Usefulness of relaxation techniques for patients with ischaemic cardiopathy: intervention in a health district].
Aten Primaria. 2005 Jun 30;36(2):78-84. doi: 10.1157/13076591.
本文引用的文献
1
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts).
Atherosclerosis. 2004 Apr;173(2):381-91.
2
[Secondary prevention of ischaemic cardiopathy: are we doing it right?].
Aten Primaria. 2004 Jan;33(1):51-3. doi: 10.1016/s0212-6567(04)78880-0.
3
[Prevention secondary to ischemic cardiopathy at the lipid level in primary care in Aragon. PRECIAR study 1].
Rev Esp Salud Publica. 2001 Mar-Apr;75(2):143-9.
4
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486.
5
[Secondary prevention of ischemic heart disease in the Cuidad Real Province, Spain. Effectiveness of lipid-lowering therapy in primary health care].
Med Clin (Barc). 2000 Sep 23;115(9):321-5.
Zotero 插件